Добавил:
Upload Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
BOOK Vasilenko.doc
Скачиваний:
12
Добавлен:
01.07.2025
Размер:
6 Мб
Скачать
☆

Iron deficiency anaemia

Iron deficiency anaemia (anaemia sideropriva gastroenterogenica) arises in the deficit of iron which is necessary for the production of haemoglobin in erythrocytes. This type of anaemia develops in patients with decreased iron absorption due to resection of the stomach ("agastric anaemia"), removal of a considerable part of the small intestine, especially of its proximal part, in intestinal diseases attended by abnormal absorp­tion, and in the iron deficit in food. The latter occurs mostly in children with prolonged milk diet and copper deficit. Increased iron demands occur during intense growth of the body. During establishment of the menstrual cycle in young girls (menstrual loss of blood and iron ions) juvenile iron deficiency anaemia (juvenile chlorosis) may develop. Chronic haemorrhage also causes iron deficiency anaemia.

Repeated (not profuse) loss of blood cause anaemization due to exhaustion of the iron store which is necessary for the production of haemoglobin in erythrocytes. Daily intake of iron with food is small, about 11-28 mg, and one fourth of this quantity is only absorbed. This is equivalent to the iron content of 15 ml of blood. Daily loss of 15 ml (or even smaller amount) of blood therefore inevitably exhausts the iron store to cause iron deficiency anaemia.

Chronic blood loss and chronic posthaemorrhagic anaemia attends many diseases of the internal organs, and in the first instance, of the gastro-intestinal tract. In most cases these are gastric or duodenal ulcer, cancer, polyposis of the stomach and intestine, haemorrhoids, and certain types of helminthiasis. Chronic posthaemorrhagic anaemia often occurs in

550

Special Part

Chapter 9. Diseases of the Blood

551

tumours of the kidneys, cavernous tuberculosis of the lungs, and in uterine haemorrhage.

Some other factors promote anaemia. These are mainly those factors which can decrease the iron stores of the body. For example, patients with secondary gastric hyposecretion and enteritis develop anaemia sooner and it runs a more severe course in the presence of even insignificant chronic haemorrhage. Gravity of chronic posthaemorrhagic anaemia arising in pa­tients with degrading tumours of the gastro-intestinal tract, kidney, or the uterus, is intensified by the toxic effect of the tumour on the haemopoiesis and by multiple metastases into the bone marrow, etc. Hydrochloric acid of the gastric juice promotes reduction of trivalent iron to its divalent form, which is easier assimilated. But recent studies show that hydrochloric acid does not play a decisive role in activation of iron absorption.

In the absence of adequate iron supply to the body or its utilization from the store, the synthesis of haemoglobin, myoglobin, and iron-containing enzymes of various cells involved in the oxidation processes is upset. This impairs nutrition of tissues and accounts for the development of many symptoms of the disease. The clinical picture of iron deficiency anaemia is explained by insufficient oxygen transport to tissues due to anaemia on the one hand, and by disordered cell respiration on the other.

Clinical picture. Slow development (within months and years) of iron deficiency anaemia accounts for actuation of the compensatory mechanisms. Most patients therefore are well adapted to the disease and can satisfactorily stand even significant anaemia.

We shall not discuss patient's complaints associated with the main disease, to which anaemia is secondary (e.g. the cause of chronic haemor­rhage). The specific complaints of anaemic patients will only be empha­sized: weakness, dizziness, dyspnoea (especially exertional), increased fatigue, noise in the ears, and fainting. Many patients develop various dyspeptic symptoms: decreased appetite, perverted taste, slight nausea, heaviness in the epigastrium after meals, and regurgitation. Diarrhoea is also frequent. Slight paraesthesia (tingling and pricking) is possible. Ex­cruciating dysphagia sometimes develops during swallowing dry or solid food in especially severe cases. This sideropenic dysphagia was first described by Rossolimo and Bekhterev in 1900-1901. Later this syndrome was described by Plummer and Vinson. The dysphagia is explained by ex­tension of the atrophic process from the stomach onto the oesophageal mucosa, and sometimes by its development in the proximal part of the soft connective-tissue membranes and bridges.

Inspection of the patient reveals pallor. Certain trophic changes in the skin, its appendages, and mucosa can be due to the general iron deficit. The skin is dry and sometimes slightly scaling. The hair is brittle, early

grey, and showing the tendency to falling. The nails become flat, sometimes spoon-like, opaque, marked by transverse folds, and brittle (koilonychia). The mouth angles often have fissures (angular stomatitis), the papillae of the tongue are levelled (atrophic glossitis). The teeth lose their luster and quickly decompose despite a thorough care. If iron preparations are taken for a long time, the teeth may blacken due to forma­tion of black iron sulphite (by the reaction of iron with hydrogen sulphide which is liberated by the carious teeth). Purulent inflammation of the gum mucosa around the tooth necks develops (alveolar pyorrhoea).

Physical examination can reveal a slight indistinct enlargement of the left ventricle, systolic murmur at the heart apex, and nun's murmur over the jugular vein (mostly on the right). Lymph nodes, liver and spleen are not enlarged.

Study of the blood reveals decreased erythrocyte and even more decreased haemoglobin content of the blood. The colour index is less than 0.85; in grave cases it is 0.6—0.5, and even lower. Microscopy of blood (Plate 30) reveals pallid erythrocytes (hypochromia), anisocytosis, and poikilocytosis. The average diameter of erythrocytes is less than normal (microcytosis). The number of reticulocytes is small. Anaemia is usually at­tended by thrombocytoleukopenia, sometimes relative monocytosis, lym-phocytosis, and eosinopenia. The iron content of the serum is decreased (1.5—2.5 times and more). The percentage of transferrin saturation also decreases (below 15).

Decreased activity of the iron-containing enzymes of tissue respiration provokes (or intensifies) atrophy of the gastro-intestinal mucosa. The study of gastric juice reveals in most cases achlorhydria or even achylia; the total amount of the excreted juice is much decreased. X-rays reveal levelled folds of the oesophageal and gastric mucosa. Oesophagoscopy and gastroscopy confirm atrophy of the oesophageal and gastric mucosa.

Course. The course of the disease is chronic and gradually progressive if the iron deficit in the body increases.

Treatment. Iron preparations (haemostimulin, etc.) are given. If the pa­tient has gastritis or peptic ulcer, the iron preparations should better be given intramuscularly or intravenously (ferbitol, fercoven, etc.). The therapy gives a comparatively rapid and permanent effect: work capacity is rapidly restored, erythrocyte and haemoglobin of blood normalize in 3—5 weeks. The patient should however be regularly (several times a year) given prophylactic courses of therapy with iron preparations in order to prevent possible relapses of the disease. The diet of patients with iron deficiency anaemia should be rich in iron salts, e.g. liver, meat, eggs, apples, dried fruits.. Efficacy of treatment of anaemia caused by chronic loss of blood depends on removal of the source of blood loss.

552 ■ Special Part

Chapter 9. Diseases of the Blood

553

•'■*'■ VITAMIN B12 (FOLIC ACID) DEFICIENCY ANAEMIA

Aetiology and pathogenesis. Vitamin B12 (folic acid) deficiency anaemia was first described by Addison in 1855. One of its forms was later given the name of Addison-Biermer anaemia. In 1868, Biermer published a more detailed description of the disease, which he called pernicious or malignant anaemia, because its prognosis was then grave and patients usually died in a few months or years after the appearance of the first symptoms.

The disease was effectively treated for the first time by Minot and Mur­phy (1926). The patients were given raw calf liver in large amounts every day. Minot and Murphy noted that distinct remissions followed in patients who were given this diet and conjectured that raw liver contained a certain substance which is necessary for normal haemopoiesis, and whose absence or deficit causes pernicious anaemia. The next stage in the study of this disease is connected with experiments carried out by Castle (1929). He noted that meat treated with gastric juice (containing various amounts of hydrochloric acid) produces an anti-anaemic effect when administered into the stomach of patients with the Addison-Biermer anaemia. Gastric juice alone, untreated meat, or meat treated with gastric juice of patients with the Addison-Biermer anaemia have no anti-anaemic effect. Castle sug­gested that a special substance, haemopoietin, was necessary for normal maturation of erythrocytes. Haemopoietin is produced by combination of a certain extrinsic factor supplied with food and the intrinsic factor con­tained in normal gastric juice.

At the present time, Castle's conjecture concerning the pathogenesis of Addison-Biermer anaemia has been proved experimentally and clinically. The extrinsic and intrinsic factors and their biological role have been studied sufficiently well. The factor is vitamin B12 (cyanocobalamin) discovered by Smith in 1948 which is contained in calf liver, kidneys, meat, eggs, and gastromucoprotein produced by the accessory cells of the glands found in the fundus of the stomach. In healthy subjects, vitamin B12 com­bines with gastromucoprotein in the stomach to give a sufficiently stable complex which protects vitamin B12 from intestinal microflora to ensure adequate absorption of vitamin B12 (mainly in the ileum). Gastromucopro­tein is absent from the gastric juice of patients with the Addison-Biermer anaemia due to pronounced atrophic gastritis. In the absence of gastromucoprotein, vitamin B12 delivered with food is decomposed by in­testinal flora and is not assimilated by the body to cause vitamin B12 deficit. In other cases, vitamin B12 (folic acid) deficiency anaemia is the result of vast resection of the stomach, severe enteritis, increased demands for vitamin B12 in pregnancy, its consumption by helminths (bothrioce-

phaliasis), and in disordered assimilation of this vitamin by the bone marrow (achrestic anaemia).

An important biological effect of vitamin B12 is activation of folic acid. Like vitamin B12, folic acid belongs to substances included in the group of vitamin B. It is contained in leaves of various plants, fresh vegetables, beans, liver, and kidneys of animals. Folic acid is deposited in the human body mainly in the liver, where it is present in inactive state. Vitamin B12 pro­motes formation of folic acid derivatives, folates, which are probably the factor necessary for haemopoiesis in the bone marrow. In conditions associated with vitamin B12 and folate defi­ciency, the synthesis of DNA is disordered; this in turn causes disorders in cell division; the cells become large and qualitatively inadequate. Erythroblasts are affected most severely: large cells of embryonal haemopoiesis, megaloblasts, are found in the bone marrow instead of erythroblasts. They are not only larger than erythroblasts; they also differ in the structure of their nuclei and protoplasm, earlier and more intense saturation with haemoglobin during their differentiation (at the stage of reticular structure of the nucleus), retarded mitotic divi­sion, and mainly in their inability to grow to normal erythrocytes. Most megaloblasts are decomposed in the bone marrow before they reach the stage of a nucleated cell. Only a small quantity of megaloblasts are differentiated to anuclear cells (megalocytes) and enter the blood vessels. Megalocytes are larger and more saturated with haemoglobin than erythrocytes and differ from them by morphological and functional inadequacy. Megalocytes have no such high oxygen-transport capacity as the erythrocytes and are quickly decomposed by reticuloen-dothelial cells: the average life of megalocytes is about three times shorter than of eryth­rocytes.

The absence of gastromucoprotein in gastric juice (like achlorhydria which usually attends this disease) is due to atrophy of the gastric mucosa. Some investigators believe that atrophy of gastric mucosa is not inflammatory in its origin as it was believed earlier (atrophic gastritis) but is a result of congenital insufficiency of its glandular apparatus which is manifested with time. In the opinion of other authors, the atrophy of gastric mucosa is caused by antibodies produced by the patient's body to the gastric glandular cells, which can however be slightly altered by toxic effects or inflammation (auto-immune mechanism).

If the second coenzyme of vitamin B12, desoxyadenosylcobalamin, is deficient, fat metabolism becomes upset with accumulation of methylmalonic acid, which is toxic for the nervous system (provokes funicular myelosis).

The Addison-Biermer anaemia attacks commonly the aged; the in­cidence among women is higher than in men.

Pathological anatomy. The skin and the organs are pallid. Small haemorrhages are possi­ble. Haemosiderosis of the liver, kidneys, bone marrow and dystrophic changes in them are characteristic. These changes are observed also in the myocardium, the brain, and the spinal cord (mostly in the lateral cord). Bone marrow is affected by hyperplasia; it is bright-red, the foci of extramedullar haemopoiesis are seen in the spleen and the lymph nodes. Histological studies show prevalence of red blood cells; many young forms, myeloblasts are seen. Megaloblasts, the large cells of perverted erythropoiesis, are especially numerous.

Clinical picture. The onset of the disease is insidious. The patient grows weaker, he complains of heart palpitation, dizziness, and dyspnoea, especially during exercise or brisk movements; the work capacity is im­paired, the appetite becomes poor; slight nausea is possible. The first com­plaint is often the burning sensation in the tongue. This is explained by the

554

Special Part

Chapter 9. Diseases of the Blood

555

development of atrophic glossitis (see below) which usually attends this disease. The patient often develops achylic diarrhoea or, on the contrary, persistent constipations. Dystrophic changes in the nervous system cause skin anaesthesia and paraesthesia; the gait is often affected in grave cases: spastic paresis develops (incomplete spastic paralysis of the lower ex­tremities); the knee reflex disappears, the function of the urinary bladder and the rectum can also be affected. All these symptoms are known as the funicular myelosis which develops due to the predominant affection of the lateral spinal columns. Symptoms of the disordered activity of the central nervous system (deranged sleep, emotional lability, etc.) become apparent.

Inspection of the patient reveals pallor of the skin and mucosa, usually with a yellowish tint due to increased decomposition of megalocytes and formation of bilirubin from the released haemoglobin, and a slight swelling of the face. The patient is not thin. Quite the reverse: most patients are well fed. The bright-red smooth and glossy tongue (because of the pronounced atrophy of the papillae) is quite characteristic of the Addison-Biermer anaemia. This symptom is known as Hunter's glossitis (W. Hunter was the first to describe this symptom). The mouth mucosa and the posterior wall of the throat are also atrophied. The tip and edges of the tongue, and also the mouth mucosa can be ulcerated. The tendency to caries is often seen in the teeth.

Pressing or tapping on the flat and some tubular bones (especially the tibia) is often painful. This is the sign of bone marrow hyperplasia. Palpa­tion can reveal a slight enlargement of the liver and the spleen.

The cardiovascular system is usually involved as well. The left border of the heart is displaced to the left, tachycardia develops, "anaemic" systolic murmur is heard at the heart apex in 75 per cent of cases; the nun's mur­mur is often heard over the jugular veins. The pulse is soft and accelerated. Most patients develop hypotension. ECG shows a certain decrease in the general voltage, the decreased T wave and the S-T interval.

Changes in the gastro-intestinal tract are pronounced. Especially characteristic is atrophy of gastric mucosa which can be revealed by X-ray examination, and more distinctly by gastroscopy. The atrophy is often focal, and the affected sites (mostly in the fundus of the stomach) can be seen as iridescent spots. Atrophy can combine with polyps in the folds of gastric mucosa and its polypous thickening. It should be remembered that anaemia, including pernicious anaemia, can be a symptom of a malignant tumour in the stomach. Cancer of the stomach occurs in patients with the Addison-Biermer anaemia 8 times more frequently than in healthy persons. Patients with this disease should therefore be systematically inspected by X-rays (by gastroscopy whenever possible). Almost all patients develop achlorhydria. In 98 per cent of cases it has the histamine-resistant

character. The total amount of juice produced during the study is usually significantly diminished; the pepsin content of the juice is very low or it cannot be determined at all (achylia). Usually achlorhydria develops many years before the first symptoms of anaemia develop.

Elevated temperature is a common symptom of vitamin B12 (folic acid) deficiency anaemia; the temperature is usually subfebrile.

Blood plasma contains slightly increased amounts of free bilirubin due to increased haemolysis of the red cells, especially megalocytes; the plasma iron content increased to 30-45 mmol/1 (170-200 ^g/ml).

The blood picture (Plate 31) is characterized by a sharp decrease in the quantity of erythrocytes (to 0.80 x 1012 per 1 1) at a comparatively high haemoglobin saturation. Despite the decreased total haemoglobin content of the blood, the colour index remains high (1.2-1.5). Red blood cells dif­fer in size (anisocytosis), with prevalence of large erythrocytes (macrocytes). Especially large slightly oval and intensely red megalocytes appear (in many cases megaloblasts are also seen). The volume of each cell increases. Many erythrocytes are oval, or they have the shape of a sickle and other shapes (poikilocytosis). Megalocytes often have remnants of the nucleus or its envelope in the form of Jolly bodies or Cabot rings. The con­tent of reticulocytes is not high. The number of reticulocytes sharply in­creases (reticulocytic crisis) during vitamin B12 therapy to indicate the beginning remission. Blood leucocytes decrease mostly at the expense of neutrophils. Eosinopenia, relative lymphocytosis, and thrombocytopenia are observed. Large neutrophils with polysegmented nuclei also occur.

The quality of erythroid precursors in a specimen of bone marrow sharply increases, by 3-4 times compared with the number of leucopoietic cells (the proportion being reverse in physiological conditions). Megaloblasts are observed in varying amounts among the erythroid precur­sors; in grave cases they are found in prevailing quantity. Both erythropoiesis and leucopoiesis are disordered. Megakaryocytes are also large, with a multi-lobed nucleus: thrombocyte separation is disordered.

Course. If untreated, the disease progresses. Before Minot and Murphy proposed their effective treatment of the disease, patients rarely survived more than 3 years. At the terminal period, many patients developed coma (coma perniciosum) with loss of consciousness, arephlexia, decreased arterial pressure and temperature, vomiting and involuntary urination.

At the present time the patient recovers from the Addison-Biermer anaemia if treated properly and if adequate prophylactic measures against relapses of the disease are taken.

Treatment. Vitamin B12 is given. In most cases treatment begins with moderate doses of the vitamin (100—300 ;tg) which is given once a day in­tramuscularly or subcutaneously. Considerable shifts in the bone marrow

556

Special Part

Chapter 9. Diseases of the Blood

557

punctate toward normalization of erythropoiesis are observed already in 24 hours after the first dose of the vitamin is given. Cells produced by division and differentiation of juvenile forms are very much like the cells produced at the corresponding stages of normal erythropoiesis. Erythropoiesis nor­malizes completely in 2 or 3 days. In 5 to 6 days of the therapy, the newly formed erythrocytes enter the blood vessels in considerable amounts: the reticulocytic crisis occurs. The number of reticulocytes in the peripheral blood increases to 20-30 per cent and then gradually decreases. General weakness lessens, work capacity is regained, and gastric secretion nor­malizes in certain cases.

Signs of funicular myelosis are eliminated much slower and do not always disappear completely. After the blood picture normalizes and the symptoms of the disease markedly subside, the patient is given maintenance therapy with small doses of vitamin B12 (100 ng weekly, or 2-3 times a month). This therapy should be maintained for the rest of the patient's life. Clinical blood counts should be done periodically. The treat­ment ensures adequate subjective condition of the patient, his work capaci­ty is regained, and relapses of the disease are prevented.

AUTO-IMMUNE HAEMOLYTIC ANAEMIA

Aetiology and pathogenesis. The pathogenesis of acquired auto-immune haemolytic anaemia (anaemia haemolytica chronica) is underlain mainly by the immunopathological shifts, which are manifested by the production of antibodies to own erythrocytes (autoag-glutinins). This condition may be caused by acute infections, poisoning, medicamentous in­toxications, especially severe forms of malignant lymphomas and collagenosis, and by some other factors. These antibodies belong to the immunoglobulin fraction and are incomplete or "weak" antibodies. Erythrocyte-bound antibodies do not cause agglutination in the blood vessels but block erythrocytes to promote their deposition in the reticulohistiocytic system (mostly in the venous sinuses of the spleen) and their capture and destruction by macrophages.

Sometimes auto-immune haemolytic anaemia is associated with the appearance of cold an­tibodies which are bound (together with the complement) to erythrocytes. Their action is manifested in the peripheral parts of the body (finger tips, ears) in overcooling. In addition to auto-agglutinins, autohaemolysins are also found in some patients. The disease may proceed in them with signs of both extra- and intravascular haemolysis.

Clinical picture. The disease develops either gradually and incidiously or acutely with a haemolytic crisis. The main complaints of the patient are weakness, dizziness, fatigue, and slightly elevated temperature. All these symptoms intensify during the haemolytic crises. Skin itching is absent. The skin is pallid with a slightly icteric hue. Applying pressure to the sternum and its percussion are painful. Palpation reveals enlarged and consolidated spleen; the liver is enlarged only slightly.

The blood erythrocyte and haemoglobin content is low, while the colour index remains normal. Erythrocytes vary in size, shape, and colour (poikilocytosis, anisocytosis, anisochromia). The average size of the erythrocytes is slightly smaller than normal (microcytosis). As distinct from congenital haemolytic anaemia, the erythrocytes of healthy individuals, as well as of patients with acquired anaemia, are less intensely coloured in the cen-

tre than by the periphery, which depends on their form (planocytes). The number of reticulocytes is high; reticulocytosis is especially marked in considerable anaemization and after the haemolytic crisis. The osmotic resistance of erythrocytes is not substantially changed. The blood serum of patients is yellowish. Study of the blood confirms increased con­tent of unbound bilirubin on which the colour depends. Hypergammaglobulinaemia is also determined. The iron content of the serum is increased. Iron is liberated in large amounts dur­ing haemolysis of erythrocytes. Owing to increased liberation of bilirubin, bile obtained by duodenal probing is very dark. The urine and faeces of the patient are darker than normal; daily excretion of stercobilin with faeces and of urobilin with urine is increased. Study of specimens of bone marrow indicates more or less significant intensification of erythropoiesis.

Both cell-bound (blocking) antibodies and those found in the free state in the plasma (con-glutinins) are revealed in the blood of patients with auto-immune haemolytic anaemia. Coombs' test is used to reveal them. A direct Coombs' test is used to reveal cell-bound (block­ing) antibodies. A suspension of the patient's erythrocytes washed in isotonic sodium chloride solution is added to the serum of a rabbit immunized by human blood globulins. Erythrocytes agglutinate if anti-erythrocytic antibodies are present on their surface. Erythrocytes of in­dividuals without acquired haemolytic anaemia are not agglutinated. Conglutinins in the serum of patients are revealed by adding erythrocytes of a healthy individual (donor) in order to absorb the antibodies on them. The cells are washed and carried through the test as des­cribed above. This is the indirect Coombs's test.

Course. The course of the disease is usually undulant. The disease is exacerbated by infec­tions, big doses of some medicines, e.g. salicylates, and by some other transient factors. In grave and long-standing cases, the patient's bone marrow may be exhausted and anaemia becomes hyporegenerative. In some cases the activity of the bone marrow may also be in­hibited by the production of auto-antibodies to erythroblastic precursors. Formation of the pigment stones in the gall bladder is a complication of the disease. Thrombophlebitis, and thrombosis of the splenic vein are other possible complications.

Treatment. Corticosteroids inhibit the production of antierythrocytic auto-antibodies. Blood transfusion should be carried out in rare cases because it can markedly enhance haemolysis.

MYELOPLASTIC SYNDROME (PANMYELOPHTHISIS)

The myeloplastic syndrome or panmyelophthisis is a large group of conditions of various aetiology and pathogenesis, whose main clinical symptoms are determined by the inhibition of blood formation in the bone marrow. Congenital (genetically determined) and acquired forms of myeloid aplasia are distinguished by the origin, and acute and chronic forms—by the course of the disease. There are also forms characterized by incomplete inhibition of the regenerative capacity of the bone marrow (hypoplasia), and complete functional inhibition (aplasia).

Various clinicohaematological variants of myeloid hypo- and aplasia are differentiated by partial (in one direction) or total (in all directions) inhibition of the regenerative capacity of the bone marrow. Most specific forms are hypo- and aplastic anaemia (in which the erythropoietic function of the bone marrow is inhibited in the first instance), agranulocytosis (inhibition of the granulocytopoietic function of the bone marrow), and also pan­myelophthisis in which the regenerative function of the bone marrow is inhibited in all direc­tions (the production of erythrocytes, granulocytes and thrombocytes is deranged more or less uniformly).

Hypo- and aplastic conditions of the bone marrow (especially hypoplastic anaemia) should not be mistaken for the hyporegenerative conditions which develop for example in chronic

558

Special Part

Chapter 9. Diseases of the Blood

559

posthaemorrhagic anaemia, grave haemolytic anaemia, and in some other conditions. As distinct from hypoplastic anaemia, a sufficiently large amount of the erythroid precursors are preserved in the bone marrow of patients with hyporegenerative anaemia; the course of the disease is not steady; if the cause of the bone marrow exhaustion is removed, its function is restored. The myeloplastic conditions do not also include cases where the decreased content of the formed elements (erythrocytes, neutrophils, thrombocytes) in the peripheral blood is ex­plained by their increased destruction in the spleen (hypersplenism) which occurs when the spleen is significantly enlarged (e.g. in cirrhosis of the liver) because the activity of the bone marrow is not decreased in these conditions but is, on the contrary, increased. Cytopenia due to metaplasia of the bone marrow (in malignant lymphomas and leucosis) and due to displace­ment of myeloproliferative tissue (in multiple myeloma, multiple metastases of cancer, etc.) does not belong to this group either.

Aetiology and pathogenesis. The aetiological factors of myeloid hypo- and aplasia are varied. These may be endogenous factors, e.g. thymus hypofunction, hereditary predisposi­tion, etc. But the exogenous factors are as a rule decisive. Among them the most important are (a) chemical poisoning, e.g. with benzene, tetraethyl lead; (b) prolonged and uncontrollable medication with some drugs, e.g. amidopyrin, butadion, cytostatic preparations (embichin, TEPA, 6-mercaptopuHne), methylthiouracyl, sulpha drugs, some antibiotics (chloram-phenicol), or increased sensitivity to them; (c) infectious and toxic effects (tuberculosis, sepsis, syphilis); (d) vegetable food that may, under certain conditions, contain toxic substances (wheathered corn, etc.); (e) ionizing radiation (radioactive substance, X-rays, etc.). It is be­lieved that the above factors act mainly by inhibiting the nucleoproteid enzymes to slow down the mitotic cell division.

A special importance is now attached to auto-aggressive mechanism in the development of some forms of myeloid hypoplasia. This mechanism consists in production of antibodies to own blood and bone marrow cells. It is possible however that the auto-antibodies are not the triggering mechanism of the disease, and their production is only secondary to the changes in the cells. Causes of myeloid aplasia remain unknown in some cases.

Pathological anatomy. Pronounced anaemia of organs, dystrophic changes and traces of multiple haemorrhage in them are revealed in classical cases. The territory of red bone mar­row is markedly contracted due to its replacement by fat tissue.

Clinical picture. The clinical picture of the disease varies depending on the prevailing direction of the inhibition of the bone marrow function. But the most characteristic symptoms are caused by anaemization, haemorrhagic diathesis, necrotization of tissues, and secondary infection (e.g. in agranulocytosis). As the disease progresses, certain changes can be seen in the clinical picture: a certain syndrome may dominate during the initial stage of the disease but later other syndromes join to indicate the total inhibition of the regenerative capacity of the bone marrow. If the disease develops gradually and remains unnoticed by the patient his first complaints are weakness, dyspnoea, rapid unmotivated fatigue, and decreased work capacity. Haemorrhagic signs are possible in thrombocytopenia: nasal bleeding, multiple ec-chymoses on the skin caused by the slightest injuries and sometimes spontaneously, gastro­intestinal and uterine haemorrhages. Fever is also characteristic.

Inspection of the patient reveals pallor; signs of resolving subcutaneous haemorrhages can be seen as bluish-purple spots, which later turn brown, and finally yellow. The skin is moist, its turgor is slightly decreased. The tourniquet and pinch tests are positive in pronounced thrombocytopenia. Changes in the heart, lungs, kidneys and the gastro-intestinal tract are usually not pathognomonic, but haemorrhages into various organs and internal and external haemorrhages are possible in the haemorrhagic syndrome. The lymph nodes, the liver and the spleen are usually not enlarged.

The blood picture shows various degrees and directions of changes in the regenerative capacity of the bone marrow. Hypo- and aplastic anaemia are characterized by markedly

decreased erythrocyte counts (to 1 x 1012 per 1 1 and below). As a rule, erythropenia is at­tended by more or less pronounced leuco- and thrombocytopenia. The number of reticulocytes decreases considerably.

Neutropenia is most pronounced in agranulocytosis: the number of leucocytes decreases to 1.5 X 109-1 x 109 and even to 0.2 x 109 per 1 1. The number of granulocytes decreases in the first instance. Their percentage content does not exceed 15-5 of the total number of leucocytes. This accounts for relative lymphocytosis and monocytosis although the absolute content of these cell forms usually remains unaltered or decreases only insignificantly. Younger forms of neutrophil leucocytes (stab neutrophils) are practically absent from the peripheral blood. Eosinophils cannot be revealed either. Some pathological changes in the nuclei and cytoplasm of neutrophils are seen: pyknosis of the nuclei and toxic granulation of the cytoplasm. Anaemia and thrombocytopenia are not pronounced during the initial period but later they become more pronounced.

In certain cases, anaemia, leucopenia and thrombocytopenia develop almost simultaneously which corresponds to the clinical picture of panmyelophthisis. When the number of thrombocytes falls below 30 x 109 per 1 1, the haemorrhagic syndrome develops.

The sternal punctate is not substantially changed during the early stages of the disease. The number of erythroid or myeloid precursors may be relatively decreased. In marked cases, the sternal punctate can contain only meagre quantity of cell elements (with prevalence of the reticular and plasma cells). Since the course of marrow aplasia is not uniform, sternal punc­tate may occasionally contain portions of bone marrow in which the changes are only in­significant. This may mislead a physician in his assessments of the disease gravity. A more correct and accurate picture of marrow haemopoiesis gives trepanobiopsy of the iliac bone by which histological preparations of the bone marrow can be obtained.

Course. Acute, subacute, and chronic forms are distinguished. The acute disease may have a fulminant course: cases were reported in which patients died in two days. The course of the forms with inhibited leucopoiesis is usually more rapid than that with the prevalent inhibition of erythropoiesis. This to a certain degree depends on a different life span of white and red blood cells.

The prognosis of the congenital and genuine myeloid aplasia is quite unfavourable. The disease progresses and the patient dies in a certain period of time. The progress of the myelotoxic form of the disease, e.g. caused by overdosage of amidopyrin, butadion or cytostatics, can often be arrested if the intake of these preparations is discontinued in due time. The patient may thus recover. The frequent cause of death in agranulocytosis is sepsis.

Treatment. The patient must be taken to hospital. In order to act on the auto-immune mechanism of the disease, corticosteroids (e.g. prednisolone) are given. If anaemization is pronounced, repeated transfusions of blood and erythrocytic mass are indicated. Blood and specially prepared leucocytic and platelet mass are transfused to patients with leucopenia and thrombocytopenia. In order to stimulate leucopoiesis, sodium nucleate, pentoxyl, and anabolic steroid hormones are given. Large doses of vitamins (especially of vitamin B,2) are indicated in all cases. Antibiotics are given in septic complications. Bone marrow transplanta­tion is now used to treat myeloid aplasia.

Haemoblastosis

Haemoblastosis is proliferation of the haemopoietic tissue; it can be diffuse and focal.

Haemoblastosis is a disease of the whole blood system characteri­zed by (1) progressive cell hyperplasia in the haemopoietic organs with

560

Special Part

Chapter 9. Diseases of the Blood

561

I ,

pronounced prevalence of proliferation of certain cells (which deter­mine the morphological essence of the disease in each particular case) over their differentiation (maturation), and the loss of their typical mor­phological and functional properties; (2) substitution (metaplasia) of these pathological cells for normal cells of the haemopoietic organs; (3) develop­ment of pathological foci of haemopoiesis in various organs.

Haemoblastosis is a comparatively rare disease. Its mortality rate is 1.7-8.1 per 100 000 population. The share of leucosis among therapeutic cases is 1.5-2.6 per cent. However the incidence of haemoblastosis, especially of acute forms, has recently increased in all countries.

Aetiology and pathogenesis. Most authors regard haemoblastosis as tumours whose morphological basis are haemopoietic cells of various organs. This has been proved by numerous observations and experiments. For example, some factors can provoke the growth of tumours and haemoblastosis. These factors are cancerogenic substances (3,4-benzpy-rene, methylcholanthrene, etc.) and radiation. There are common features in the character of tissue proliferation in haemoblastosis and tumours. Metabolic disorders in haemoblastosis-affected cells and tumour cells have been proved to be of the same type (anaerobic glycogenolysis prevails in them). Concurrence of haemoblastosis and tumour is not infrequent. Ad­ministration of an extract of tumour tissue to experimental animals causes haemoblastosis in some of them; and vice versa, administration of the bone marrow or lymph node punctates of haemoblastosis patients may provoke the growth of tumours.

There are two main theories explaining the aetiology of haemoblastosis and tumours. These are the virus and the genetic theory. At the present time more than 20 viruses have been isolated that can cause haemoblastosis in animals. Attempts at isolating the virus of the main forms of haemoblastosis in man end in failure. According to the genetic theory, haemoblastosis develops due to the congenital or acquired damage to the chromosome structures of low differentiated cells of the haemopoietic organs. A clone theory has been launched recently, according to which haemoblastosis arises due to primary chromosome mutation in one of the haemopoietic cells with its subsequent multiplication and formation of a clone of blast cells.

Nomenclature and classification of haemoblastosis. All types of haemoblastosis are designated in accordance with the name of cells which determine the cytomorphological essence of the disease. For example, acute myeloblastic leucosis, chronic erythromyelosis, lymphoid leucosis, etc. The traditional names of certain types of haemoblastosis describe the major syndrome of the disease, e.g. osteomyelosclerosis, macroglobuli-naemic haemoblastosis, etc. Certain types of haemoblastosis have a second

name (the name of the author who was the first to study or describe the disease), e.g. Waldenstrom disease, Cesaris disease, etc. Like other tumours, haemoblastoses can be benign and malignant.

More than 30 forms of haemoblastosis have been well studied. Recent advances in haematology have made it possible to improve the classifica­tion of the diseases.

The following two groups of haemoblastosis are distinguished: leucosis and haematosarcoma (malignant lymphoma).

Leucosis* is the disease of the haemopoietic cells with the primary locus of the tumour in the bone marrow. The release of tumour (leucosis) ceus into the blood cause leukaemia as a symptom of the disease. The following forms of leucosis are distinguished.

  1. Acute leucosis in which haemopoiesis is transformed at the expense of low differentiated blast cells or precursor cells of the 3rd and even 2nd series. Haemocytoblastosis is now absent from the modern classification because it has been proved that the "youngest" cell of haemopoiesis is not the haemocytoblast but three consecutive series of precursor cells. Various forms of acute leucosis are differentiated mainly by the cytochemical characteristics of leukaemic cells. In adult patients, acute myeloblastic leucosis occurs in 60 per cent and lymphoblastic leucosis in 25-30 per cent of cases. Other forms occur less frequently.

  2. Chronic leucosis, in which haemopoiesis is transformed at the ex­ pense of more mature cells of differentiated haemopoiesis. Separate forms are differentiated quite easily by cytomorphological signs of leukaemic cells: chronic myeloid leucosis, chronic lymphoid leucosis, chronic erythromyelosis, erythraemia, etc.

It should be remembered that differentiation between acute and chronic leucosis first of all depends on the cytomorphological sign (the degree of cell maturity) rather than on the clinical course of the disease, although both these signs coincide in most cases. Acute leucosis may continue for a year or even longer, while a patient with chronic leucosis may die within a few months. Therefore, the diagnosis, in addition to the definition of the type of leucosis (acute, chronic), should also determine its course. It is also important to remember that acute leucosis almost never transforms into the chronic form because it is characterized by anaplasia (the cells lose ability to further maturation) of the initial elements of haemopoiesis. Quite the reverse, chronic leucosis can be exacerbated with formation of non-differentiated elements (blasts) in the foci of haemopoiesis and in the

* Translator's note: the term "leukaemia" is generally used in western literature while "leucosis" is the accepted usage in the USSR. In view of the authors' preference we have re­tained their usage, while both terms are used more or less synonymously.

37-1556

562

Special Part

Chapter 9. Diseases of the Blood

563

peripheral blood. Exacerbations may be spontaneous or provoked by some causes of progressive anaplasia of leukaemic cells. Chronic leucosis in the stage of blast crisis is similar to acute leucosis.

Leucosis can have the following three variants: with considerable in­crease in the quantity of pathological cells in the peripheral blood (leukaemic form), with moderate increase in their number (subleukaemic form), and without appreciable leukaemic shift in the presence of normal or decreased quantity of white blood elements (aleukaemic form).

Leukaemic forms of leucosis are sometimes difficult to differentiate from leukaemoid reactions (extreme leucocytosis to 0.1 x 1012 per 1 1 of blood) which are observed in some infectious diseases. In leukaemoid reac­tions, the leucocyte counts can be shifted to the left, to myeloblasts. But this leucocytosis in leukaemoid reactions is characterized by its potential reversibility (provided the causes are removed) and by preservation of the functional and morphological properties of leucocytes. Although leukaemic cells are called normal haemopoietic cells, in fact they cannot perform their usual function, and patients with leucosis have decreased im­munity. The cells cannot differentiate into more mature cells; they decom­pose at a quicker rate. It has been established that leukaemic cells have an inhibiting effect on normal haemopoiesis.

Leucosis is characterized by lability, pronounced ability to transforma­tion with exacerbation of the process (with the progress of anaplasia to less differentiated cells) and with involvement of other haemopoietic cells. Moreover, both morphological and clinical changeability of the process are characteristic. In some cases more or less long remissions can occur spon-s taneously or under certain effects (infectious disease, treatment). Remis­sions are then followed by exacerbations (to blast crisis).

Each type of leucosis is a static expression of the specific features of clinico-cytomorphological picture of the diseases and at the same time can also include certain elements of the dynamic process. This should be taken into consideration during establishing a diagnosis and in prescribing the appropriate therapy.

Haematosarcoma (malignant lymphoma, or regional tumours with their possible generalization) is also a tumour of haemopoietic cells but its localization is mostly extra-marrow and focal. Lymphogranulomatosis is the most common haemoblastosis. Paraproteinaemic haemoblastosis (mutliple myeloma, Waldenstrom's disease) is a special form arising from precursors of B lymphocytes and characterized by production of pathological globulins. Reticulosarcoma and some other diseases are also special forms of paraproteinaemic haemoblastosis.

Leucosis can also transform into some types of malignant lymphomas, except lymphogranulomatosis. The reverse process is also possible: ample

leukaemic cells appear in the blood and bone marrow in malignant lym­phomas, i.e. the blood picture and the course of the disease are similar to those observed in leucosis.

ACUTE LEUCOSIS

Acute leucosis is characterized by profuse proliferation of the youngest (blast) elements of blood with their subsequent disturbed differentiation and also with development of foci of pathological haemopoiesis in various organs. Lympho- and myeloblastic forms of the disease are common.

Acute leucosis occurs at any age, but men and women from 20 to 30 are mostly affected.

Pathological anatomy. The skin and the internal organs are anaemic. Mucosa (especially in the fauces and mouth) and often the skin are affected by necrotic ulcers and multiple haemorrhages. Haemorrhages into the internal organs also occur. Lymph nodes, the spleen and the liver are moderately enlarged. Histological studies of these organs and of the bone marrow show that they are as if "stuffed" with non-differentiated cells of blood (blasts).

Clinical picture. The onset of the disease is in most cases acute or subacute: high temperature (remittent or hectic), profuse sweating, chills, pronounced weakness, pain in the bones, and other general symptoms resembling those of acute septic affections. Pain in the throat is often one of the first complaints: swallowing becomes painful because of necrotic ulceration of the throat and fauces. For this reason the disease is often mistaken for necrotic tonsillitis and only further observation of the patient and the study of the bone marrow and blood help the physician establish a correct diagnosis. Fever, chills and sweating, which are so characteristic of acute leucosis, are explained by the pyrogenic effect of purines released in great quantity during the decomposition of immature leucocytes. Fever can also be caused by secondary infections; despite the markedly increased pro­duction of white blood cells, their function is inadequate, and resistance of leucosis patients to various infections decreases.

In some cases the onset of the disease is gradual, with non-pronounced general symptoms: slight weakness, indisposition, rapid fatigue, and subfebrility. The condition then worsens and a complete clinical picture of the disease develops. Anaemia and various haemorrhagic complications and secondary infection develop.

Inspection of the patient usually reveals grave condition from the very onset of the disease. In the terminal period the condition is particularly grave: the patient is passive, answers the doctor's questions with difficulty, or is unconscious. The skin is pallid, sometimes with yellowish or greyish hue, and moist; its turgor is decreased. Traces of subcutaneous and in-

37*

564

Special Part

Chapter 9. Diseases of the Blood

565

tracutaneous haemorrhages can be seen. The tourniquet and the pinch tests are positive; haemorrhage is considerable at points of injections. Necrosis and bed-sores are possible. Necrosis of the mucosa, especially of the mouth and throat, is especially pronounced. Ulcerous and necrotic tonsillitis, gingivitis, and stomatitis are quite characteristic of the disease. Necrotized surfaces are covered with a poorly removable grey or yellowish coat. When removed, it reveals bleeding ulcers. The breath of the patient is putrefac­tive. Palpation reveals enlargement of separate groups of the lymph nodes, spleen, and the liver. The heart borders are broadened; tachycardia, systolic murmur at the heart apex (due to dystrophic processes in the heart muscle), and anaemia are revealed. Pericarditis and pleuritis are possible. Each haematological form of leucosis is characterized (though not necessarily) by some special clinical features.

The blood of parents contains increased number of white blood cells: to 1 x 1011 and even 2 x 10u per 1 1 (in rare cases even this figure may be exceeded) (Plate 32). Subleukaemic forms of the disease can occur. Leucopenia can develop in some cases at the early stage of acute leucosis. Leucopenia is then succeeded by leucocytosis. The most specific haematological sign of the disease is the presence of blast cells in the peripheral blood. All blast cells are similar morphologically but special cytochemical reactions can be used to differentiate between them. Prevalence of their certain forms is determined by the haematological variant of leucosis (acute lymphoblastic, acute myeloblastic, acute monoblastic leucosis, etc.). The immature forms may amount to as high as 95 and even 99 per cent. Leukaemic cells often have some specific defects in their nuclear and cytoplasmic structure. Only the youngest and the most mature cells can be revealed in the blood of most patients with acute leucosis, while intermediate forms are absent (hiatus leucaemicus). Eosinophils and basophils are absent; other cell forms are decreased significantly not only relatively but also absolutely. Thrombocytopenia and anaemia are observed which can be explained by the displacement of megakariocytes and erythroblasts from the bone marrow by vigorously proliferating blast cells and also by the prevalent development in the direc­tion of leucopoiesis. Anaemia may intensify due to haemorrhage (characteristic of this disease) and also due to the intensified haemolysis of erythrocytes. Coagulability of blood and the bleeding time are abnormal in most cases; ESR sharply increases.

The bone marrow punctate contains 80-90 per cent of leukaemic blast cells, which displace all other cell elements.

Course. The course of the disease is progressive. Prognosis is un­favourable. The average life expectancy of patients with acute leucosis is about 2 months; in separate cases from 2 days to 18 months. But modern

therapy can prolong the patients' life to 2-3 years; in rare cases to 5 years and more.

Treatment. Combined therapy, including 3-5 preparations, depends on the clinico-haematological variant of the disease. Corticosteroids (e.g. prednisolone) in large doses are prescribed together with cytostatic (6-mercaptopurin, vincristin, methotrexate, etc.). Anaemia is removed by blood transfusion and by preparations preventing haemorrhagic complica­tions (vicasol, calcium chloride, aminocaproic acid). If secondary infection arises, antibiotics are indicated. Intense vitamin therapy is also useful.

CHRONIC MYELOLEUCOSIS

Chronic myeloleucosis is the most common variety of leucosis. It develops from precursors of myelopoiesis. It is characterized by myeloid hyperplasia of the bone marrow attended by delayed maturation of the myeloid elements at a certain stage of their development and by myeloid metaplasia of the spleen, liver, lymph nodes and other organs. Karyological studies reveal, in the overwhelming majority of cases, the so-called Philadelphia (Ph1) chromosome in the myeloid precursors. Chronic myeloleucosis occurs at any age but its incidence at the age of 20-45 is higher.

Pathological anatomy. The internal organs are pallid and anaemic. The spleen is marked­ly enlarged, consolidated; it has traces of past ischaemic infarctions and new infarctions. Microscopy does not reveal spleen follicles; diffuse proliferation of the myeloid tissue can be seen. The liver is enlarged and myeloid proliferation can be traced by the course of the liver capillaries and the periportal layers. The lymph nodes are somewhat enlarged; their section is greyish-red. Myeloid tissue can be seen in them (as well as in the other organs).

The bone marrow is juicy, bright-red or greyish-red; it displaces fat marrow in the tubular bones to a lesser or greater extent. Red bone marrow is represented mainly by the myeloid elements; the more acute the process, the greater the prevalence of less differentiated elements.

Clinical picture. The initial symptoms of the disease are not specific: weakness, fatigue, excess sweating, and subfebrile temperature. The symp­toms become more pronounced with time and the patient consults a doc­tor. The work capacity decreases appreciably, weakness increases, sweating becomes profuse, the body temperature rises periodically to 37.5—39 °C; cachexia develops. A common symptom is the feeling of heaviness in the left part of the abdomen which depends on the pronounced enlargement of the spleen. Pain may be due to a considerable distension of the spleen cap­sule. Splenic infarction is manifested by piercing pain which intensifies during breathing. Pain in the bones is not infrequent. It is due to hyperplasia of the myeloid tissue.

566

Special Part

Chapter 9. Diseases of the Blood

567

Fig. 109. A patient with chronic myeloid leucosis (marked are the borders of the enlarged spleen and liver).

Myeloid infiltration in various internal organs can be the cause of some additional symptoms, such as dyspeptic signs in affections of the gastro­intestinal tract, coughing in the presence of infiltrations in the lungs and the pleura, neurological changes due to affection of the brain, the spinal cord, nerve radices, etc. In the terminal period of the disease, the heart is overloaded due to pronounced anaemization; dyspnoea and oedema develop (their origin being dependent also on hypoproteinaemia). Throm-bocytopenia and shifts in the blood coagulation system cause haemor-rhagic complications. Inspection of the patient helps physician assess his general condition and determine (approximately) the stage of the disease (stage I—the initial symptoms, stage II—pronounced symptoms, and stage III—dystrophy; this is the terminal stage). The terminal stage is characterized by pronounced cachexia and considerable enlargement of the abdomen due to markedly enlarged liver and spleen (Fig. 109). The skin is pallid, with a yellowish or greyish hue; it is flaccid and moist. The legs are affected by oedema. Gingivitis and necrosis of the mouth mucosa are possible. Palpation reveals moderate enlargement of the lymph nodes of various groups. The liver and especially the spleen are markedly enlarged. It is believed that no other disease is attended by enlargement of the spleen to the extent to which it is enlarged in the terminal stage of chronic

myeloleucosis. The liver and the spleen are firm. In the presence of infarc­tions of the spleen it is tender to palpation. Peritoneal friction sound can be heard over the spleen by auscultation. Applying pressure to the bones and tapping over them are painful.

The leucocyte count is markedly high (Plate 33). It can be 3 x 1011 and even 6 x 1011 per 1 1. Leucocyte count can first only slightly exceed the normal level but later it increases, gradually or suddenly. Temporary remissions are possible, especially in the appropriate therapy. In addition to the main form of myeloleucosis characterized by a considerable increase in the white blood cells count (leukaemic), there may be cases with their moderately increased (subleukaemic) and normal counts (aleukaemic). Study of the blood smears reveals mainly cells of granulocytic series which make 95-97 per cent of all white blood elements. There are many im­mature forms among them (myelocytes, promyelocytes, and even myeloblasts). During exacerbation, the number of young forms markedly increases. Only the youngest cells, myeloblasts, and a relatively small number of mature granulocytes (stab and segmented ones) can be revealed in the blood, while the intermediate forms are absent (hiatus leucaemicus). Basophils and eosinophils are usually present in the smear; their percentage can even be increased. Basophilia in 4-5 per cent of cases is regarded as a sign of myeloleucosis. The number of lymphocytes and monocytes decreases to 3—0.5 per cent in grave cases with significant leucocytosis, but their absolute amount in the blood does not change substantially. Red blood changes are only observed at stages II and III of the disease, when anaemia joins the process and progresses. Erythrocyte and haemoglobin content of the blood decreases synchronously. The colour index therefore remains within the normal range (0.8-1.0). Thrombocytopenia develops as the terminal period approaches. ESR usually increases to 30—70 mm/h.

The content of the erythroid precursors markedly decreases in the bone marrow (especially when the disease approaches its terminal stage). Cells of the myeloid series prevail (especially juvenile forms: promyelocytes, myelocytes, and myeloblasts). Megakaryocyte count slightly increases in the first half of the disease. Characteristic also is the increase in the number of basophilic and eosinophilic promyelocytes and myelocytes.

Course. The course of the disease is progressive, sometimes with tran­sient spontaneous remissions. Before modern methods of treatment of the disease were introduced into clinical practice, the average life expectancy of patients was 2.5—3 years (sometimes to 10 years). Today the life of patients is prolonged more significantly. Patients die of cachexia, anaemization in­compatible with life, haemorrhagic complications, or from a joining infec­tion.

Treatment. Myelosan and other cytostatics are prescribed, usually in

568

Special Part

Chapter 9. Diseases of the Blood

569

combination with 6-mercaptopurine, prednisolone, etc. Patients with a marked splenomegaly are given radiotherapy or dopan. Repeated transfu­sions of blood or packed red cells are indicated in cases with pronounced anaemization.

CHRONIC LYMPHOID LEUCOSIS

Chronic lymphoid leucosis is now regarded as a benign tumour of the immunocompetent tissue. Its haematological basis is mainly B-lymphocytes (morphologically mature but functionally inadequate). Chronic lymphoid leucosis is characterized by systemic hyperplasia of the lymphoid apparatus, lymphoid metaplasia of the spleen, bone marrow, and other organs. Chronic lymphoid leucosis is a common form of leucosis. It usually occurs in the middle-aged and aged individuals (from 35 to 70), mostly in men.

Pathological anatomy. The lymph nodes of various groups are enlarged significantly. Their section is grey or greyish-red. The pattern of the lymph nodes is blurred; microscopy reveals accumulation of lymphoid cells, among which juvenile forms occur. The tonsils are enlarged, their structure is indistinct; microscopy reveals large accumulations of lymphocytes and lymphopoietic cells. The spleen is markedly enlarged but not to the extent to which it is enlarged in chronic myeloleucosis. Its structure is indistinct because of diffuse hyperplasia of the lymphoid tissue. Lymphatic infiltrations are seen in the liver, the stomach wall, pancreas, kidneys, and the skin; in other words, all organs can be affected. Lymphoid metaplasia of the bone marrow is observed.

Clinical picture. The initial symptoms are general weakness, indisposi­tion, and rapid fatigue. The first symptom which troubles the patient and makes him feel like consulting a doctor is usually enlargement of the sub­cutaneous lymph nodes. General weakness gradually increases, excess sweating develops along with subfebrile temperature. Depending on a par­ticular enlarged lymph node group and the organ affected by lymphoid in­filtration, additional symptoms develop: dyspepsia, diarrhoea (in affection of the gastro-intestinal tract), dyspnoea and attacks of asphyxia (in com­pression of the trachea and bronchi by the bifurcation lymph nodes), erythema, dryness and itching of the skin (in leukaemic lymphodermia), etc. Lymphoid metaplasia of the bone marrow may cause haemorrhagic symptoms (due to thrombocytopenia) and anaemia. Leukaemic infiltration can cause radicular pain and exophthalmos. Diffuse lymphatic prolifera­tion in the nasopharynx can develop.

Enlarged lymph nodes can often be revealed during inspection of the patient. Lymph nodes of one or several groups are often enlarged; later all other lymph nodes become also involved. The tonsils can be enlarged too.

Skin infiltration is attended by its consolidation, reddening, dryness and scaling. At the terminal stage, the patients are extremely thin (cachexia).

Palpation is used to assess accurately the enlargement of the lymph nodes and their properties. The lymph nodes are elastic-pasty; they do not fuse with the skin or with one another, and are painless in most cases. They can grow to the size of a hen egg. Even markedly enlarged, the lymph nodes never ulcerate or suppurate (as distinct from tuberculosis affection of the nodes). The liver and the spleen are enlarged and consolidated. In­farctions of the spleen can occur; its palpation then becomes tender.

Leucocyte counts in the leukaemic form of the disease are as high as 3 x 1011 per 11, and more. Lymphocytes make 80—95 per cent of the white blood (Plate 34); they are mostly mature. The structure of their nucleus and cytoplasm is sometimes quite peculiar: the cells are very soft and are easily destroyed when preparing a smear; specific Botkin-Gumprecht shadows are formed. Small amounts of juvenile cells, prolymphocytes and lymphoblasts, occur. During exacerbation their number increases. The relative quantity of neutrophils is much decreased (to 20-4 per cent). The blood picture is less specific in subleukaemic and aleukaemic forms of the disease, where lymphocytosis is usually less pronounced. Anaemia and thrombocytopenia (mainly of the auto-immune genesis) join at the ter­minal period.

Study of the punctate of the bone marrow reveals its lymphoid metaplasia: great quantity of lymphoid cells are found (to 50 and even 90 per cent in especially grave cases). The number of cell elements of the granulocytic and erythroid precursors is decreased. The results of studying the lymph node punctate are less convincing because lymphoid cells are common elements of its parenchyma while the hyperplastic character of the lymphoid tissue is sometimes difficult to determine.

Course. The disease progresses in cycles or gradually. The average life expectancy of patients is 4-5 years. Some survive for 10-12 years and over. The patients die of secondary infections, usually pneumonia (which is promoted by inhibition of humoral immunity), of haemorrhagic complica­tions, and cachexia.

Treatment. Active treatment is not given during the initial period of the disease (like in chronic myeloleucosis). Special attention is given to nor­malization of conditions of work and rest of the patients, who must be fed an adequate diet rich in vitamins and proteins. The patient should walk in the open air. X-ray therapy is given in the presence of toxicosis or if the disease is rapidly progressing. The enlarged lymph nodes and the spleen are irradiated. Leukeran, prednisolone, cyclophosphane and other chemical cytostatics are given. Blood transfusion is indicated in anaemia and throm­bocytopenia.

570

Special Part

Chapter 9. Diseases of the Blood

571

ERYTHRAEMIA

Erythraemia (chronic erythromyelosis, Vaquez' disease) is a benign myeloproliferative disease characterized by total hyperplasia of the bone marrow cell elements, which is more pronounced in the erythroid precur­sor. Erythraemia was first described by the French clinicist Luis Vaquez in 1892. Aged males are mostly affected.

Erythraemia should be differentiated from erythrocytosis which may be a symptom of some other diseases (chronic diseases of the lungs and the heart, essential hypertension, some kidney diseases, etc.) and erythrocytosis developing in the presence of hypoxia (at high altitudes, e.g. in highland; less frequently in pilots). The symptoms of the main disease prevail in the clinical picture of symptomatic erythrocytosis. During remis­sion, or in cases of recovery, the erythrocyte count in the peripheral blood normalizes. Symptomatic erythrocytosis is not attended by neutrophilic leucocytosis or thrombocytosis, or else splenomegaly, which are common in erythraemia.

Pathological anatomy. Pronounced hyperaemia of the organs and the presence in them of old and new haemorrhages are characteristic. Red bone marrow is affected by hyperplasia; it displaces fat from the diaphysis of the tubular bones. Histological studies reveal increased number of the erythroid series cells. The liver and the spleen are mildly enlarged and plethoric. The left ventricle of the heart is often hypertrophied (in arterial hypertension).

Clinical picture. The onset of the disease is slow and indistinct. When the symptoms are activated, the patient complains of headache, heaviness in the head and noise in the ears, exertional dyspnoea, impaired memory, and skin itching. Vision and hearing function are also impaired in some cases. Pain in the abdomen can develop, probably due to excess blood delivery to the internal organs. Unbearable and burning pain can transient­ly develop in the finger tips (erythromelalgia), which can be explained by transient vascular spasms.

Inspection of the patient reveals peculiar plethoric redness of the expos­ed skin (face, neck, hands). The tongue and the lips are bluish-red, the eye conjunctiva is hyperaemic. This peculiar colour of the skin and mucosa is due to overfilling of the surface vessels with blood and its slow movement in the vessels. The greater part of haemoglobin is thus converted into its reduced form. Palpation reveals moderately enlarged spleen and liver. Tapping over flat bones and exerting pressure on them are painful, which is characteristic of bone marrow hyperplasia.

Arterial pressure (both systolic and diastolic) is often increased. It is believed that arterial hypertension is a compensatory reaction of the vessels to the increased viscosity of blood. In these cases palpation of the apex beat and electrocardiography reveal left-ventricular hypertrophy. ... i

The erythrocyte count increases and is usually from 6 x 1012 to 8 x 1012 per 1 1, and more; haemoglobin increases to 180-220 g/1; the colour index is less than 1. The total blood circulatory volume increases significantly (1.5—2.5 times) mainly at the expense of increased erythrocyte count. The blood reticulocyte content increases to 15-2O%owhich indicates intensified regeneration of erythrocytes. Polychromasia of erythrocytes is observed; separate erythroblasts can be found in the smear. The number of white blood cells also increases (1.5—2 times) at the expense of neutrophils, whose content is 70-85 per cent. The nuclear shift to the left is observed. The number of eosinophils, less frequently of basophils, increases. The number of thrombocytes increases sharply to 1.5 x 1012-2 x 1012 per 1 1 of blood. ESR is slow, blood viscosity increases significantly, while coagulability of blood and the bleeding time remain normal.

Histological study of the bone marrow (obtained by trepanobiopsy) shows significantly increased number of cells of the erythroid series. The number of juvenile cells of the granulocytic series and of megakaryocytes is also increased.

Course. The disease progresses slowly. The average life expectancy of patients is 10-14 years. The outcome of the disease is myelofibrosis with progressive hypoplastic anaemia or transformation into myeloleucosis. Most frequent complications are thrombosis of the cerebral vessels, spleen, lower extremities, and less frequently of other parts of the body. Tendency to bleeding also develops which is due to both functional inadequacy of thrombocytes and the low relative content of fibrinogen in the blood. Erythraemia patients often develop gastroduodenal ulcer.

Treatment. Radioactive phosphorus (32P) is the best therapeutic means for erythraemia. It produces a cytostatic effect on haemopoiesis in the bone marrow. Clinical remission, lasting from 1 to 3 years is attained in most cases. New cytostatics (myelosan and marcofan) are also used. Symp­tomatic therapy includes phlebotomy (500 ml) at 5—7 day intervals.

LYMPHOGRANULOMATOSIS ,',',.

Lymphogranulomatosis is a systemic disease in the group of malignant lymphomas and is characterized by the specific malignant affection of the lymph nodes, the spleen, and other organs. The disease was first described by Thomas Hodgkin in 1832. Hence another name, Hodgkin's disease.

Aetiology and pathogenesis. It is believed that the disease is underlain by lymphogenic metastasis from the primary focus, which obeys the law of tumour propagation. Lymphogranulomatosis is possibly a tumour of histiocytes in which the chromosome set is disordered (Melburn chromosome). : , ,...

572

Special Part

Chapter 9. Diseases of the Blood

573

Pathological anatomy. The main changes are enlargement of various lymph nodes. Their histological studies reveal focal three-stage growths of the granuloma cells. The stage of dif­fuse hyperplasia of the lymph node is followed by focal, and then diffuse proliferation of the reticular and endothelial cells, and also of the cells of juvenile connective tissue. The presence of the Berezovsky-Sternberg cells is especially characteristic. These giant cells have 1, 2 or 3 large nuclei with large nucleoli. Fibrosis develops at the third stage. Necrotic foci are sometimes observed. Lymphogranulomatosis is characterized by a varied histological picture and simultaneous presence of various phases of lymphogranulomatous growths in various lymph nodes. The spleen is enlarged and firm; the section shows many light-grey foci of lym­phogranulomatous proliferations which account for the porphyritic texture. Proliferation of lymphogranulomatous tissue can be seen in other organs, e.g. in the stomach, intestine, liver, etc.

Clinical picture. Weakness and general indisposition are in most cases the first appreciable signs of the disease. Skin itching is among them. It can be excruciating and the patient scratches the skin. The temperature elevates and hidrosis develops. Attacks of fever are first infrequent, but later become more constant. The temperature curve has a specific pattern, to reach 38—39.5 °C at its peaks. The difference between the morning and evening temperatures is 1-2 °C. The main symptom for which the patient would first consult the doctor is gradual swelling of some part of the body, mostly of the neck (due to growth of the lymph nodes). Both surface and deep-seated lymph nodes become enlarged. Considerable enlargement of the lymph nodes of any internal group can involve some additional changes in the patient's condition and cause complaints. For example, when the lymph nodes grow to compress the mediastinum, the trachea or bronchi the patient develops dyspnoea, cough, pain and the pressing sensation in the chest. If the recurrent nerve is compressed, the corresponding vocal cord is affected by paresis and voice becomes hoarse. Lymphogranulomatous af­fection of the stomach causes symptoms of dyspepsia (abdominal pain, regurgitation, vomiting, etc.). If the abdominal lymph nodes and the in­testine are involved, persistent constipation may develop.

Findings of physical examination show enlargement of the lymph nodes which is the most characteristic sign of the disease. The cervical lymph nodes (mostly on the right side of the neck) become enlarged in more than 50 per cent cases; the nodes of the other side of the neck become involved later. Next involved are submandibular, supra- and subclavicular, axillary, femoral, and inguinal lymph nodes; less frequently the lymph nodes of the other regions (occipital, ulnar, etc.) are involved.

Newly involved nodes are soft, while the old ones become very firm. They fuse together to form conglomerates but do not adhere to the skin. The nodes are painless, they do not suppurate or open, as distinct from actinomycosis- or tuberculosis-affected nodes (scrofuloderma). If a group of lymph nodes is enlarged considerably, the overlying skin becomes dark-

red and then bronze due to disordered circulation; it does not however get thin.

Inspection of the patient reveals some symptoms caused by compres­sion of the vessels and nervous trunks by the enlarged lymph nodes (regional cyanosis, dilatation of the veins, Homer's symptom, etc.). Ab­dominal lymph nodes can be palpated if their enlargement is considerable. A tuberous tumour can be felt in the mesogastric region round the um­bilicus. The spleen is enlarged and firm; it is tender in the presence of perisplenitis. Enlargement of the liver is less characteristic. Enlargement of the mediastinal lymph nodes can best of all be revealed by X-rays.

Hypochromic anaemia and neutrophilic leucocytosis are usually found; lymphocyte counts (absolute and relative quantities) are low. Eosinophilia and thrombocytopenia may also occur. ESR is increased: at the terminal stage it is 50—70 mm/h. Study of the punctate of the bone marrow is not quite informative but the Berezovsky-Sternberg cells may often be observ­ed.

Histological study of lymph node bioptates (Plate 35) reliably confirms the diagnosis of lymphogranulomatosis. The cell composition of the lym­phogranulomatous tissue is as a rule quite varied but its most specific ele­ment are granulomas with giant cells to 30—80 ^m in diameter (Berezovsky-Sternberg polynuclear cells which do not occur in other diseases). Study of the content of lymph nodes is more accessible but less informative.

Course. The disease is progressive; remissions are followed by exacer­bations. Anaemia and cachexia develop gradually. The prevalent affection of a particular group of lymph nodes accounts for the clinical picture of the disease. In some cases compression of a vital organ can accelerate the disease and its outcome. The patient may also die of a secondary infection. The average life expectancy of the patients is from 3 to 4 years; some pa­tients however survive for 6-8 years and more.

Treatment. Radiotherapy is quite effective. It can give remissions lasting as long as several months (after irradiation of the enlarged lymph nodes). Chemical cytostatics (usually their combinations) are used.

Haemorrhagic Diathesis

Haemorrhagic diathesis is the disease characterized by the tendency to bleeding and repeated haemorrhages; they may occur spontaneously and may be caused by injuries; injury can be quite insignificant, which other­wise would never provoke bleeding in a normal individual.

Aetiology and pathogenesis. These are quite varied. Some types of haemorrhagic diathesis are hereditary but many of them can be caused by some external factors.

574

Special Part

Chapter 9. Diseases of the Blood

575

Avitaminosis (deficit of vitamins C and P) is an especially predisposing factor. Some infections (long-standing sepsis, louse-born typhus, virus haemorrhagic fevers, icterohaemorrhagic leptospirosis), allergic condi­tions, some diseases of the liver, kidneys, and of the blood system can also provoke the onset of haemorrhagic diathesis.

Haemorrhagic diathesis can be classified by the pathogenesis into two major groups: (1) haemorrhagic diathesis due to disordered capillary permeability (haemorrhagic vasculitis, vitamin C deficiency, some infec­tious diseases, trophic disorders, etc.); (2) haemorrhagic diathesis due to disorders in the blood coagulation and anticoagulation system. The latter group is further subdivided into the following conditions:

A. Haemorrhagic diathesis caused by disordered blood coagulation system:

  1. first phase: congenital deficit of plasma components of thrombo- platelet formation (factors VIII, IX, XI), haemophilias A, B, C, etc.; deficit of thrombocytic components (thrombocytopathy, e.g. throm- bocytopenic purpura; see below);

  2. second phase: deficit of plasma component of thrombin forma­ tion—factors II, V, X, the presence of antagonists to them and of their in­ hibitors;

  3. third phase: deficit of plasma components of fibrin formation- factors I (fibrinogen) and XII.

B. Haemorrhagic diathesis caused by accelerated fibrinolysis (due to in­ creased synthesis of plasmin and insufficient synthesis of antiplasmin).

C. Haemorrhagic diathesis caused by disseminated intravascular coagulation (thrombohaemorrhagic syndrome or coagulopathy of con­ sumption) in which all procoagulants are utilized during massive in­ travascular coagulation and the fibrinolysis system is activated.

This concise classification of haemorrhagic diathesis is only conven­tional because several pathogenic factors are often involved. This classification covers a very large group of diseases, both hereditary and ac­quired, and also secondary syndromes arising against the background of the main disease (metastasizing malignant tumour, burn disease, etc.)

Clinical picture. The general clinico-morphological symptoms of haemorrhagic diathesis are haemorrhages into various organs and tissues, external and internal haemorrhages (from the gastro-intestinal tract, lungs, uterus, kidneys, etc.) and secondary anaemization. The disease is com­plicated by dysfunction of the haemorrhage-affected organs, by hemiparesis in disordered cerebral circulation, regional paralysis and paresis in compression of large nervous trunks by haematomas, haemar-throsis in repeated haemorrhages into the joints, etc.

Despite the great variety of haemorrhagic diatheses and certain diagnostic difficulties, accurate diagnosis is quite important for efficacious

therapy in each particular case. The aetiological and pathogenetic factors of the disease should be properly considered for an accurate diagnosis. Haemorrhagic diathesis is the subject of special study of senior medical students. Here we shall only acquaint the reader in general with throm-bocytopenic purpura (Werlhof's disease).

The prophylaxis of hereditary (familial) haemorrhagic diathesis in­cludes medico-genetic studies that may give the wife and husband the necessary information and advice concerning possible complications in their offspring; if haemorrhagic diathesis is not hereditary but acquired, measures should be taken to preclude development of diseases that may pjpmote the onset of haemorrhagic diathesis.

Thrombocytopenic purpura (Werlhof's disease). Thrombocytopenic purpura is a haemorrhagic diathesis due to the deficit of blood platelets. The disease was first described by Paul Werlhof in 1735. Throm­bocytopenic purpura occurs mostly in young females.

The aetiology and pathogenesis of the disease are unknown. It has only been established that the immune-allergic mechanism is positively involved in about 50 per cent cases: anti-thrombocytic antibodies are produced and fixed on the surface of thrombocytes to damage them and to prevent their normal separation from megakaryocytes. The triggering factors (the im­petus to production of auto-antibodies) may be infection, toxicosis, in­dividual hypersensitivity to certain foods and medicines. In some cases the disease is caused by hereditary insufficiency of certain enzyme throm-bocyte systems which is probably activated by some additional factors.

Pathological anatomy. Multiple haemorrhages in the skin and the internal organs are characteristic. The spleen may be considerably enlarged. Separation of thrombocytes from megakaryocytes in the bone marrow is disordered (according to histological findings).

Clinical picture. The main symptom of the disease is the appearance on the skin and mucosa of multiple haemorrhages in the form of small dots (petechiae) or large spots (ecchymoses). Haemorrhage may be spontaneous and due to insignificant injuries, mild contusion, pressure on the skin, etc. Haemorrhagic lesions are first purple, then they darken to cherry-red and brown, and then lighten to yellow and disappear in several days. But new lesions develop to succeed the disappearing ones. Bleeding from the nose, gastro-intestinal tract, kidneys or uterus are not infrequent; haemorrhages into the internal organs (brain, fundus oculi, myocardium, etc.) are also possible. Grave and prolonged bleedings arise in extraction of teeth or in other minor operations. The tourniquet test (and especially the pinch test) are positive. The spleen and the lymph nodes are usually not enlarged; tap­ping on the bones is painless.

Thrombocyte counts are usually less than 50 x 109 per 1 1; in some cases only single blood platelets can be found in preparations. The degree

576

Special Part

of bleeding can be assessed by the degree of thrombocytopenia. Hypochromic anaemia can develop after profuse bleeding. The clotting time is normal in most cases, but it can be slightly longer (due to the deficit of thromboplastic factor HI of blood platelets). The bleeding time increases to 15-20 min and more; clot retraction is disordered. Throm-boelastography reveals greatly increased reaction and clotting time.

Course. Both acute and chronic recurrent forms of the disease are observed. The patient dies of profuse bleeding and haemorrhages into the

vital organs.

Treatment. Removal of the spleen is indicated in grave cases: the number of thrombocytes increases in the blood of a patient and haemor­rhage stops in a few days following the operation. The effect of splenec-tomy is probably explained by decreased decomposition of blood platelets in the spleen and by the removal of the inhibiting effect that the spleen has on thrombocytopoiesis. Blood transfusion is useful for haemostasis and blood substitution. Repeated transfusion of thrombocytic mass gives positive haemostatic effect. Vitamin P, vitamin C, calcium chloride and vicasol are given to strengthen the vascular walls. Since the allergic factor is involved in the pathogenesis of the disease, corticosteroid hormones are quite effective in certain cases.

Chapter 10 ENDOCRINE SYSTEM AND METABOLISM

Соседние файлы в предмете [НЕСОРТИРОВАННОЕ]